![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsored by: |
Wake Forest University |
---|---|
Information provided by: | Wake Forest University |
ClinicalTrials.gov Identifier: | NCT00695578 |
The purpose of this research study is to evaluate the use of Biafine Cream on wounds created by removal of actinic keratosis using cryotherapy in a clinical setting.
Condition | Intervention | Phase |
---|---|---|
Actinic Keratosis |
Drug: Biafine |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Single Blind (Investigator), Single Group Assignment, Efficacy Study |
Official Title: | A Randomized Right/Left Clinical Trial to Evaluate the Use of Biafine Cream Versus Standard Care in Subjects With Actinic Keratosis Post Cryotherapy |
Enrollment: | 20 |
Study Start Date: | October 2006 |
Study Completion Date: | February 2008 |
Primary Completion Date: | June 2007 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 50 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, North Carolina | |
Wake Forest University Health Sciences Dermatology | |
Winston Salem, North Carolina, United States, 27157 |
Principal Investigator: | Steve Feldman, MD, PhD | Wake Forest University |
Responsible Party: | Wake Forest University Health Sciences ( Steve Feldman, MD PhD ) |
Study ID Numbers: | 00000341, 31335 |
Study First Received: | June 9, 2008 |
Last Updated: | February 12, 2009 |
ClinicalTrials.gov Identifier: | NCT00695578 |
Health Authority: | United States: Institutional Review Board |
Keratosis Alginic acid Skin Diseases Mineral Oil Tylosis |